Literature DB >> 24791626

Normocalcemic hyperparathyroidism: preoperatively a disease, postoperatively cured?

Heather C Stuart1, Adrian Harvey1, Janice L Pasieka2.   

Abstract

BACKGROUND: Up to 44% of primary hyperparathyroidism patients have elevated parathyroid hormone (ePTH) with normal calcium postparathyroidectomy (PTx). The question is whether the surgical approach affects the incidence of this phenomenon.
METHODS: Patients with hyperparathyroidism and presumed single-gland disease on preoperative imaging who underwent PTx between 1994 and 2008 were identified and contacted for long-term follow-up. PTx was either a focused approach (minimally invasive approach [MIP]) or a bilateral neck exploration (BNE).
RESULTS: In total, 171 patients had PTH measured postoperatively (95 MIP and 76 BNE); 30 of 171 (17%) had ePTH with normal calcium (MIP 21 [22%] and BNE 9 [12%], P = .08). This occurred within 2 years in 48% and 67% and after 2 years in 52% and 33%, MIP vs BNE, respectively. Four patients recurred, 2 MIP and 2 BNE.
CONCLUSIONS: There is a trend toward a higher incidence of ePTH in patients having undergone an MIP. The etiology of ePTH is multifactorial but may represent an early recurrence.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Minimally invasive; Normocalcemia; Parathyroidectomy; Postoperative hyperparathyroidism

Mesh:

Substances:

Year:  2014        PMID: 24791626     DOI: 10.1016/j.amjsurg.2014.01.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  What Should We Tell Our Patients? Lifetime Guarantee or is it 5- to 10-year Warranty on a Parathyroidectomy for Primary Hyperparathyroidism?

Authors:  Janice L Pasieka
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 2.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

Review 3.  Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.

Authors:  Joaquín Gómez-Ramírez; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

4.  A COMPARATIVE ANALYSIS OF THE INITIAL EAST EUROPEAN CENTER EXPERIENCE WITH A WESTERN HIGH-VOLUME CENTER FOR OPEN MINIMALLY INVASIVE PARATHYROIDECTOMY (OMIP) AS TREATMENT OF PRIMARY HYPERPARATHYROIDISM.

Authors:  R M Neagoe; D T Sala; I Pascanu; S Voidazan; L Wang; M Lansdown; I T Cvasciuc
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

5.  Evaluation of postural parathyroid hormone change in patients with primary hyperparathyroidism.

Authors:  Cevdet Aydin; Sefika Burcak Polat; Ahmet Dirikoc; Berna Ogmen; Neslihan Cuhaci; Reyhan Ersoy; Bekir Cakir
Journal:  Int J Endocrinol       Date:  2014-09-01       Impact factor: 3.257

6.  A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients.

Authors:  Shaobo Cao; Ya Hu; Yiming Zhao; Zhe Su; Zhiyan Xu; Xiang Gao; Quan Liao; Yupei Zhao
Journal:  Oncotarget       Date:  2017-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.